Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing pain therapy. This includes comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. Topics include Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation and Novel Drugs, Natural Products and Nutraceuticals. Types of inflammatory conditions include gastrointestinal disease (e.g. upper GI ulceration and bleeding, ulcerative colitis, Crohn's disease), various arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS).

The journal has seven main interest areas:

  • Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
  • Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
  • Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
  • Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
  • Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
  • Muscle-immune interactions during inflammation: mechanisms of inflammation and anti-inflammatory actions of therapeutic agents on skeletal muscle under conditions of aging or injury.
  • Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics

Requirements for manuscripts on the pharmacological or inflammatory properties of natural products are described in the editorial Inflammopharmacology Vol. 15, issue 5 or on the journal website: www.springer.com/10787

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Reviews all aspects of inflammation and its pharmacological control
  • Compares different inflammatory states, and their causes
  • Examines the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions
  • Covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation and Novel Drugs, Natural Products and Nutraceuticals

Journal information

Editor-in-Chief
  • Kim D. Rainsford
Deputy Editor
  • Phillip Berry
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.473 (2020)
Impact factor
4.700 (2020)
Five year impact factor
9 days
Submission to first decision (Median)
277,185 (2021)
Downloads

Latest articles

This journal has 65 open access articles

About this journal

Electronic ISSN
1568-5608
Print ISSN
0925-4692
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CLOCKSS
  6. CNKI
  7. CNPIEC
  8. Chemical Abstracts Service (CAS)
  9. Dimensions
  10. EBSCO Academic Search
  11. EBSCO Discovery Service
  12. EBSCO STM Source
  13. EBSCO Science & Technology Collection
  14. EMBASE
  15. Google Scholar
  16. Japanese Science and Technology Agency (JST)
  17. Journal Citation Reports/Science Edition
  18. Medline
  19. Meta
  20. Naver
  21. OCLC WorldCat Discovery Service
  22. Pathway Studio
  23. Portico
  24. ProQuest-ExLibris Primo
  25. ProQuest-ExLibris Summon
  26. Reaxys
  27. SCImago
  28. SCOPUS
  29. Science Citation Index Expanded (SCIE)
  30. TD Net Discovery Service
  31. UGC-CARE List (India)
  32. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG